观察性研究发现常规血液指标异常或提示未来痴呆风险
Routine blood test may suggest future dementia risk
一项发表于《Alzheimer's Disease Journal》的大型观察性研究分析了316,542名韩国成年人的健康筛查记录,发现血红蛋白水平异常与未来15年内痴呆诊断存在关联。
A common blood test already carried out during routine health checks may contain clues about a person's long-term risk of dementia, according to research being presented at the ECNP Congress in Munich and published in the Journal of Alzheimer's Disease.
The study followed 316,542 Korean adults aged 40 and older who had a national health screening in 2004–2005, then used national health insurance records to track new dementia diagnoses until the end of 2019—up to 15 years later. The researchers categorized the participants into five groups, from the 20% with the lowest hemoglobin levels to the 20% with the highest hemoglobin levels.
Researchers found that people in the lowest 20% of hemoglobin levels had a 16% higher risk of all-cause dementia than those in the group with the lowest dementia rate, while those in the highest 20% had a 7% higher risk.
The pattern differed by dementia type. For Alzheimer's disease, the increased risk was mainly seen among the 20% of people with the lowest hemoglobin levels, who had a 14% higher risk than the reference group.
For vascular dementia (caused by reduced blood flow to the brain), the 20% with the lowest hemoglobin levels had a 19% higher risk, whereas the 20% with the highest hemoglobin levels had an 18% greater risk of developing dementia. For vascular dementia, however, the relationship did not follow a simple pattern across all five hemoglobin groups. The association was also clearer and more consistent in women than in men.
Hemoglobin is the protein in red blood cells that carries oxygen around the body. Low hemoglobin is commonly associated with anemia, while unusually high hemoglobin may reflect factors such as smoking, dehydration, lung or heart disease, or other medical conditions.
Presenting the work at the 39th ECNP Congress in Munich, lead researcher Dr. Hyun Soo Kim, an assistant professor at Dong-A University College of Medicine in Busan, South Korea, said, "The findings do not show that hemoglobin itself causes dementia, but suggest that abnormal hemoglobin levels may be a visible marker of wider physical vulnerability relevant to brain health."
He continued, "Dementia is one of the fastest-growing health challenges in aging societies, and there are not many treatments and no cure. Identifying simple, accessible markers of future risk could help researchers and clinicians better understand how whole-body health relates to brain health over time."
The study is notable because hemoglobin is already measured in standard blood tests around the world. Unlike specialized scans or emerging biomarkers, it is inexpensive, familiar to doctors and patients, and often already available in routine medical records.
Kim added, "A blood test most people already get at a routine checkup may say something about their brain health many years later. In this large Korean cohort, people with unusually low hemoglobin—and, to a smaller degree, those with unusually high hemoglobin—were more likely to develop dementia.
"This does not prove that hemoglobin causes dementia, but it supports the idea that general physical health, including the body's ability to carry oxygen, matters for long-term brain health."
The researchers stress that this was an observational study and so comes with several caveats. It can identify associations, but it cannot prove that low or high hemoglobin directly causes dementia. Early, undiagnosed dementia processes may also affect nutrition, frailty, weight loss or anemia, which could contribute to the observed relationship.
Kim said, "We want to emphasize that the findings should not be interpreted as advice to take iron supplements, to raise hemoglobin levels, or to lower high hemoglobin levels in order to prevent dementia. An abnormal hemoglobin result should instead be discussed with a doctor, because it may point to underlying health issues that deserve attention."
Commenting, Dr. Lindsey Sinclair (University of Southampton) said, "There is a growing body of evidence that physical health and brain health are intertwined. We are also increasingly aware that changes supporting better brain health, be they medical or lifestyle changes, are important in midlife to reduce the risk of later dementia.
"While this study shows a possible link between hemoglobin levels and dementia risk, more work is required to understand if this link is present in people from a wider range of backgrounds and what can best be done to reduce dementia risk in people with the lowest and highest levels of hemoglobin."
Sinclair was not involved in this work; this is an independent comment.
Publication details
Ji Hee Song et al., The association between hemoglobin level and risk of developing dementia, Journal of Alzheimer's Disease (2026). DOI: 10.1177/13872877261443702
Journal information: Journal of Alzheimer's Disease
Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Andrew Zinin
Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →
Citation: Routine blood test may suggest future dementia risk (2026, October 12) retrieved 12 October 2026 from https://medicalxpress.com/news/2026-10-routine-blood-future-dementia.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com